Multiple Cerebral Microbleeds and Atypical β-amyloid Deposits: A Case Report

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2019 Dec 22

PMID 31860978

Citations 1

Authors

Jin San Lee

Kyung Mi Lee

Hyug-Gi Kim

Il Ki Hong

Affiliations

Soon will be listed here.

Abstract

Rationale: Cerebral microbleeds are increasingly recognized in various neurological disorders such as cerebral amyloid angiopathy (CAA), Alzheimer disease, and stroke. The presence and number of cerebral microbleeds are known to be independent predictors of cognitive impairment.

Patient Concerns: A 73-year-old woman visited our memory disorder clinic complaining of progressive memory impairment, which started 2 years ago.

Diagnoses: The patient had innumerable cortical/subcortical cerebral microbleeds in the entire brain. We diagnosed the patient with amnestic mild cognitive impairment due to CAA. Interestingly, only focal β-amyloid deposits at the bilateral parietal cortices were seen on amyloid positron emission tomography (PET) scan.

Interventions: We have observed changes in her cognitive function without any medication.

Outcomes: The cognitive function of the patient was unchanged during the follow-up period.

Lessons: Our case was interesting in a few aspects, including the number of cerebral microbleeds and the atypical β-amyloid deposition pattern on amyloid PET scan. Further studies on more cases are needed to evaluate β-amyloid burden and distribution patterns in CAA.

Citing Articles

Cerebral Microbleeds and Antiplatelet Therapy in Mongolian and Han Patients with Ischemic Cerebrovascular Disease.

Fu H, Ge L, Liang J J Multidiscip Healthc. 2024; 17:5789-5798.

PMID: 39649369 PMC: 11625424. DOI: 10.2147/JMDH.S491665.

References

Petersen R, Lopez O, Armstrong M, Getchius T, Ganguli M, Gloss D . Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2017; 90(3):126-135. PMC: 5772157. DOI: 10.1212/WNL.0000000000004826. View

Petersen R . Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004; 256(3):183-94. DOI: 10.1111/j.1365-2796.2004.01388.x. View

Busse A, Hensel A, Guhne U, Angermeyer M, Riedel-Heller S . Mild cognitive impairment: long-term course of four clinical subtypes. Neurology. 2006; 67(12):2176-85. DOI: 10.1212/01.wnl.0000249117.23318.e1. View

Charidimou A, Farid K, Tsai H, Tsai L, Yen R, Baron J . Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance. J Neurol Neurosurg Psychiatry. 2017; 89(4):410-417. DOI: 10.1136/jnnp-2017-316851. View

Ding J, Sigurdsson S, Jonsson P, Eiriksdottir G, Meirelles O, Kjartansson O . Space and location of cerebral microbleeds, cognitive decline, and dementia in the community. Neurology. 2017; 88(22):2089-2097. PMC: 5447401. DOI: 10.1212/WNL.0000000000003983. View

Akoudad S, Wolters F, Viswanathan A, de Bruijn R, van der Lugt A, Hofman A . Association of Cerebral Microbleeds With Cognitive Decline and Dementia. JAMA Neurol. 2016; 73(8):934-43. PMC: 5966721. DOI: 10.1001/jamaneurol.2016.1017. View

Poels M, Ikram M, van der Lugt A, Hofman A, Niessen W, Krestin G . Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology. 2012; 78(5):326-33. DOI: 10.1212/WNL.0b013e3182452928. View

KNUDSEN K, Rosand J, Karluk D, Greenberg S . Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001; 56(4):537-9. DOI: 10.1212/wnl.56.4.537. View

Petersen R, Doody R, Kurz A, Mohs R, Morris J, Rabins P . Current concepts in mild cognitive impairment. Arch Neurol. 2001; 58(12):1985-92. DOI: 10.1001/archneur.58.12.1985. View

10.

Charidimou A, Martinez-Ramirez S, Reijmer Y, Oliveira-Filho J, Lauer A, Roongpiboonsopit D . Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation. JAMA Neurol. 2016; 73(8):994-1001. PMC: 5283697. DOI: 10.1001/jamaneurol.2016.0832. View

11.

Greenberg S, Vernooij M, Cordonnier C, Viswanathan A, Salman R, Warach S . Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009; 8(2):165-74. PMC: 3414436. DOI: 10.1016/S1474-4422(09)70013-4. View

12.

Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K . Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am J Neurodegener Dis. 2014; 3(1):19-32. PMC: 3986608. View

13.

Viswanathan A, Greenberg S . Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011; 70(6):871-80. PMC: 4004372. DOI: 10.1002/ana.22516. View